#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chordoma VEXAS syndrome Still's disease Palmar-plantar erythrodysaesthesia syndrome Endocrine ophthalmopathy Granulomatosis with polyangiitis Antisynthetase syndrome Autoinflammation with infantile enterocolitis Rhabdomyosarcoma Facioscapulohumeral muscular dystrophy Acute graft versus host disease ABO haemolytic disease of newborn Glioma Cutaneous lupus erythematosus Oesophageal adenocarcinoma stage III More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Basic Information Alagille syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Treatment Pemphigus – Life with Disease Mucopolysaccharidosis II – Life with Disease Kearns-Sayre syndrome – Trials in Disease Pulmonary sarcoidosis – Trials in Disease Methylmalonic acidaemia – Basic Information Epidermolysis bullosa – Treatment Glycogen storage disease type I – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Doxazosin Filgrastim DNL593 Rbd4059 Encorafenib Tulmimetostat Defactinib Loncastuximab Tesirine Empasiprubart Spartalizumab Amitriptyline Hydrochloride Cagrilintide Nystatin Aliskiren Pralatrexate ALE.P02 Buclizine Hydrochloride Futibatinib GOCATAMIG TX000045 More therapies…

    Learn about Your Condition

    Hysterectomy Eclampsia Retinopathy of prematurity Ocular myasthenia Mitral valve disease Chondrosarcoma metastatic Hepatic encephalopathy Fontan procedure Dyspnoea Juvenile idiopathic arthritis Colitis ulcerative Oesophageal cancer metastatic Subdural haematoma Renal transplant Breast cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Pimecrolimus
    • Tacrolimus
    • Amlitelimab
    France Germany Greece Italy The Netherlands Poland +1

  • Study of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    Investigated Drugs:
    • Daxdilimab
    Bulgaria Czechia Denmark France Germany Greece +1

  • Study on the Effects of GSK3915393 for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Gsk3915393
    France Germany Italy The Netherlands Poland Spain

  • Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain

  • Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Carboplatin
    • Cisplatin
    Austria Bulgaria France Germany Greece Hungary +4

  • Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Pimecrolimus
    • Tacrolimus
    • Amlitelimab
    Bulgaria Czechia France Germany Italy Spain

  • Study on Lorlatinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer After First-line Treatment Failure

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Lorlatinib
    France

  • Study on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Ralinepag
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Ralinepag
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Deutivacaftor
    • Tezacaftor
    • Vanzacaftor
    Austria Belgium Czechia Denmark France Germany +10
Previous Page
1 … 39 40 41 42 43 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!